OP0174 Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients with Spondylitis and Peripheral Joint Involvement: Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study

A. Kavanaugh; L. Puig; A.B. Gottlieb; C. Ritchlin; Y. You; Y. Wang; A.M. Mendelsohn; M. Song; P. Rahman; I. McInnes

doi:10.1136/annrheumdis-2015-eular.3096

OP0174 Efficacy and Safety of Ustekinumab in Psoriatic Arthritis Patients with Spondylitis and Peripheral Joint Involvement: Results from a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.3096 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 136.1-136 ◽

Cited By ~ 3

Author(s):

A. Kavanaugh ◽

L. Puig ◽

A.B. Gottlieb ◽

C. Ritchlin ◽

Y. You ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Controlled Study ◽

Joint Involvement ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

228. Secukinumab, A Human Anti-Interleukin-17A Monoclonal Antibody, Improves Active Psoriatic Arthritis and Inhibits Radiographic Progression: Efficacy and Safety Data from a Phase 3 Randomized, Multicentre, Double-Blind, Placebo-Controlled Study

Rheumatology ◽

10.1093/rheumatology/kev089.115 ◽

2015 ◽

Keyword(s):

Monoclonal Antibody ◽

Psoriatic Arthritis ◽

Radiographic Progression ◽

Safety Data ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Interleukin 17A

Download Full-text

Long‐term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin‐23, Through 2 Years: Results from a Phase 3, Randomized, Double‐blind, Placebo‐controlled Study Conducted in Biologic‐naïve Patients with Active Psoriatic Arthritis

Arthritis & Rheumatology ◽

10.1002/art.42010 ◽

2021 ◽

Author(s):

Iain B. McInnes ◽

Proton Rahman ◽

Alice B. Gottlieb ◽

Elizabeth C. Hsia ◽

Alexa P. Kollmeier ◽

...

Keyword(s):

Monoclonal Antibody ◽

Psoriatic Arthritis ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Term Efficacy ◽

Interleukin 23

Download Full-text

SAT0396 Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis: 2-Year Results from A Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2014-eular.2283 ◽

2014 ◽

Vol 73 (Suppl 2) ◽

pp. 737.2-738 ◽

Cited By ~ 1

Author(s):

A. Kavanaugh ◽

L. Puig ◽

A. Gottlieb ◽

C. Ritchlin ◽

S. Li ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A phase 3, randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of erenumab in migraine prevention: primary results of the arise trial

Journal of Neurology Neurosurgery & Psychiatry ◽

10.1136/jnnp-2017-316074.63 ◽

2017 ◽

Vol 88 (5) ◽

pp. e1.63-e1 ◽

Cited By ~ 8

Author(s):

David Dodick ◽

Messoud Ashina ◽

David Kudrow ◽

Michel Lanteri-Minet ◽

Vera Osipova ◽

...

Keyword(s):

Controlled Study ◽

Migraine Prevention ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Results of a phase 3, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of astodrimer gel for prevention of recurrent bacterial vaginosis

American Journal of Obstetrics and Gynecology ◽

10.1016/j.ajog.2019.10.087 ◽

2019 ◽

Vol 221 (6) ◽

pp. 672-673 ◽

Cited By ~ 3

Author(s):

J. Schwebke ◽

B. Carter ◽

A. Waldbaum ◽

C. Price ◽

A. Castellarnau ◽

...

Keyword(s):

Bacterial Vaginosis ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

OP0234 EFFICACY AND SAFETY OF BRODALUMAB, AN ANTI-INTERLEUKIN-17 RECEPTOR A MONOCLONAL ANTIBODY, IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS: A 16 WEEK RESULTS OF A PHASE 3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

10.1136/annrheumdis-2019-eular.6888 ◽

2019 ◽

Cited By ~ 2

Author(s):

James Cheng-Chung Wei ◽

Tae-Hwan Kim ◽

Mitsumasa Kishimoto ◽

Takuya Morishige ◽

Naoki Ogusu ◽

...

Keyword(s):

Monoclonal Antibody ◽

Axial Spondyloarthritis ◽

Controlled Study ◽

Interleukin 17 ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

1.71 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (P302) ASSESSING THE EFFICACY AND SAFETY OF SPN-812 (EXTENDED-RELEASE VILOXAZINE) 200 AND 400MG FOR THE TREATMENT OF ADHD IN ADOLESCENTS

Journal of the American Academy of Child & Adolescent Psychiatry ◽

10.1016/j.jaac.2019.08.476 ◽

2019 ◽

Vol 58 (10) ◽

pp. S170

Author(s):

Azmi Nasser ◽

Gregory D. Busse ◽

Joseph Hull ◽

Fatima Chowdhry ◽

Toyin Adewole ◽

...

Keyword(s):

Extended Release ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

OP0218 Efficacy and safety results of guselkumab, an anti-il23 monoclonal antibody, in patients with active psoriatic arthritis over 24 weeks: a phase 2a, randomized, double-blind, placebo-controlled study

10.1136/annrheumdis-2017-eular.1164 ◽

2017 ◽

Cited By ~ 6

Author(s):

A Deodhar ◽

A Gottlieb ◽

W-H Boehncke ◽

B Dong ◽

Y Wang ◽

...

Keyword(s):

Monoclonal Antibody ◽

Psoriatic Arthritis ◽

Controlled Study ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

SAT0271 Continued Improvement of Signs and Symptoms in Ustekinumab-Treated Patients with Active Psoriatic Arthritis: Week 52 Results of a Phase 3, Multicenter, Double-Blind, Placebo-Controlled Study

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2013-eular.1996 ◽

2013 ◽

Vol 72 (Suppl 3) ◽

pp. A674.2-A675

Author(s):

A. Kavanaugh ◽

I. B. McInnes ◽

A. B. Gottlieb ◽

L. Puig ◽

P. Rahman ◽

...

Keyword(s):

Psoriatic Arthritis ◽

Signs And Symptoms ◽

Controlled Study ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients

Journal of Cystic Fibrosis ◽

10.1016/j.jcf.2015.12.004 ◽

2016 ◽

Vol 15 (4) ◽

pp. 495-502 ◽

Cited By ~ 33

Author(s):

Patrick A. Flume ◽

Donald R. VanDevanter ◽

Elizabeth E. Morgan ◽

Michael N. Dudley ◽

Jeffery S. Loutit ◽

...

Keyword(s):

Cystic Fibrosis ◽

Controlled Study ◽

Efficacy And Safety ◽

Phase 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text